Authors:
DUMONTET C
KETTERER N
ESPINOUSE D
NEIDHARDT EM
MOULLET I
THIEBLEMONT C
SALLES G
COIFFIER B
Citation: C. Dumontet et al., REDUCED PROGRESSION-FREE SURVIVAL IN ELDERLY PATIENTS RECEIVING INTENSIFICATION WITH AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELL REINFUSION FOR MULTIPLE-MYELOMA, Bone marrow transplantation, 21(10), 1998, pp. 1037-1041
Authors:
KETTERER N
SALLES G
MOULLET I
DUMONTET C
ELJAAFARICORBIN A
TREMISI P
THIEBLEMONT C
DURAND B
NEIDHARDTBERARD EM
SAMAHA H
RIGAL D
COIFIER B
Citation: N. Ketterer et al., FACTORS ASSOCIATED WITH SUCCESSFUL MOBILIZATION OF PERIPHERAL-BLOOD PROGENITOR CELLS IN 200 PATIENTS WITH LYMPHOID MALIGNANCIES, British Journal of Haematology, 103(1), 1998, pp. 235-242
Authors:
KETTERER N
SALLES G
DUMONTET C
MOULLET I
ESPINOUSE D
NEIDHARDTBERARD EM
THIEBLEMONT C
BOUAFIA F
COIFFIER B
Citation: N. Ketterer et al., FLUDARABINE MAY INCREASE THE TOXICITY OF PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION, British Journal of Haematology, 102(1), 1998, pp. 204-205
Authors:
KETTERER N
SALLES G
RABA M
ELJAAFARICORBIN A
ESPINOUSE D
TREMISI P
DUMONTET C
MOULLET I
NEIDHARDTBERARD EM
BOUAFIA F
COIFFIER B
Citation: N. Ketterer et al., HIGH CD34(-BLOOD PROGENITOR-CELL (PBPC) TRANSPLANTATIONS() CELL COUNTS DECREASE HEMATOLOGICAL TOXICITY OF PERIPHERAL), British Journal of Haematology, 102(1), 1998, pp. 204-204
Authors:
COIFFIER B
KETTERER N
HAIOUN C
ENGERT A
TILLY H
MA D
JOHNSON P
LISTER A
FEURINGBUSKE M
RADFORD JA
REYES F
DIEHL V
Citation: B. Coiffier et al., A MULTICENTER, RANDOMIZED PHASE-II STUDY OF RITUXIMAB (MABTHERA) AT 2DOSAGES IN PATIENTS WITH RELAPSED OR REFRACTORY INTERMEDIATE GRADE LYMPHOMA OR IN ELDERLY PATIENTS IN FIRST-LINE THERAPY, British Journal of Haematology, 102(1), 1998, pp. 238-238
Authors:
COIFFIER B
HAIOUN C
KETTERER N
ENGERT A
TILLY H
MA D
JOHNSON P
LISTER A
FEURINGBUSKE M
RADFORD JA
CAPDEVILLE R
DIEHL V
REYES F
Citation: B. Coiffier et al., RITUXIMAB (ANTI-CD20 MONOCLONAL-ANTIBODY) FOR THE TREATMENT OF PATIENTS WITH RELAPSING OR REFRACTORY AGGRESSIVE LYMPHOMA - A MULTICENTER PHASE-II STUDY, Blood, 92(6), 1998, pp. 1927-1932
Authors:
KETTERER N
SALLES G
RABA M
ESPINOUSE D
SONET A
TREMISI P
DUMONTET C
MOULLET I
ELJAAFARICORBIN A
NEIDHARDTBERARD EM
BOUAFIA F
COIFFIER B
Citation: N. Ketterer et al., HIGH CD34(-BLOOD PROGENITOR-CELL TRANSPLANTATION() CELL COUNTS DECREASE HEMATOLOGIC TOXICITY OF AUTOLOGOUS PERIPHERAL), Blood, 91(9), 1998, pp. 3148-3155
Authors:
KETTERER N
SALLES G
ESPINOUSE D
DUMONTET C
NEIDHARDTBERARD EM
MOULLET I
BOUAFIA F
BERGER F
FELMAN P
COIFFIER B
Citation: N. Ketterer et al., INTENSIVE THERAPY WITH PERIPHERAL STEM-CELL TRANSPLANTATION IN 16 PATIENTS WITH MANTLE CELL LYMPHOMA, Annals of oncology, 8(7), 1997, pp. 701-704
Authors:
DUMONTET C
DRAI J
BERARD EMN
MOULLET I
KETTERER N
ESPINOUSE D
SALLES G
COIFFIER B
Citation: C. Dumontet et al., PROGNOSTIC VALUE OF SERUM LDH ISOENZYME PROFILES IN PATIENTS WITH AGGRESSIVE LYMPHOMA, Blood, 90(10), 1997, pp. 3889-3889
Authors:
KETTERER N
SALLES G
TREMISI P
ESPINOUSE D
RABA M
DUMONTET C
MOULLET I
NEIDHARDTBERARD EM
BOUAFIA F
COIFFIER B
Citation: N. Ketterer et al., ANALYSIS OF FACTORS INFLUENCING 300 PERIPHERAL-BLOOD PROGENITOR-CELL (PBPC) COLLECTIONS IN 273 PATIENTS (PTS) TREATED FOR LYMPHOPROLIFERATIVE DISEASES, Blood, 90(10), 1997, pp. 939-939
Authors:
KETTERER N
SALLES G
RABA M
ESPINOUSE D
TREMISI P
DUMONTET C
MOULLET I
NEIDHARDTBERARD EM
BOUAFIA F
COIFFIER B
Citation: N. Ketterer et al., HIGH CD34(-BLOOD PROGENITOR-CELL (PBPC) TRANSPLANTATIONS() CELL COUNTS ALLOW FURTHER DECREASE IN HEMATOLOGICAL TOXICITY OF AUTOLOGOUS PERIPHERAL), Blood, 90(10), 1997, pp. 1650-1650
Authors:
COIFFIER B
KETTERER N
HAIOUN C
REYES F
DIEHL V
TILLY H
MA D
JOHNSON P
LISTER A
HIDDEMANN G
CROWTHER D
CAPDEVILLE R
Citation: B. Coiffier et al., A MULTICENTER, RANDOMIZED PHASE-II STUDY OF RITUXIMAB (CHIMERIC ANTI-CD20 MAB) AT 2 DOSAGES IN PATIENTS WITH RELAPSED OR REFRACTORY INTERMEDIATE OR HIGH-GRADE NHL (IHG-NHL) OR IN ELDERLY PATIENTS IN FIRST-LINETHERAPY, Blood, 90(10), 1997, pp. 2271-2271
Authors:
LEYVRAZ S
LANGE A
PEREY L
KETTERER N
BOSQUEE L
ROSTI G
PASINI F
HAMDAN O
HUMBLET Y
CETTO GL
MARANGOLO M
Citation: S. Leyvraz et al., HIGH-DOSE SEQUENTIAL CHEMOTHERAPY (ICE) UNDER CIRCULATING PROGENITOR CELLS (CPC) PROTECTION IN PATIENTS WITH SMALL-CELL LUNG-CARCINOMA (SCLC) - PRELIMINARY-REPORT ON A MULTICENTRIC STUDY, European journal of cancer, 31A, 1995, pp. 90-90
Authors:
LEYVRAZ S
KETTERER N
PEREY L
BAUER J
VUICHARD P
GROB JP
SCHNEIDER P
VONFLIEDNER V
LEJEUNE F
BACHMANN F
Citation: S. Leyvraz et al., INTENSIFICATION OF CHEMOTHERAPY FOR THE TREATMENT OF SOLID TUMORS - FEASIBILITY OF A 3-FOLD INCREASE IN DOSE INTENSITY WITH PERIPHERAL-BLOOD PROGENITOR CELLS AND GRANULOCYTE-COLONY-STIMULATING FACTOR, British Journal of Cancer, 72(1), 1995, pp. 178-182
Authors:
LEYVRAZ S
KETTERER N
VUICHARD P
VONFLIEDNER V
LEJEUNE F
SCHNEIDER P
GROB JP
BACHMANN F
Citation: S. Leyvraz et al., SEQUENTIAL HIGH-DOSE COMBINATION CHEMOTHERAPY WITH GRANULOCYTE-COLONY-STIMULATING FACTOR AND PERIPHERAL-BLOOD PROGENITOR CELLS IN PATIENTS WITH SOLID TUMORS - INTENSIFICATION LIMITED BY NONHEMATOLOGIC TOXIC EFFECTS, Journal of the National Cancer Institute, 85(23), 1993, pp. 1962-1964